FindTrial
Sign In

RELATION BETWEEN EGG/EMBRYO FORMATION WITH USING EGG FORMING DRUGS (TABLET CLOMIPHENE CITRATE)

CORRELATION OF ANTI MULLERIAN HORMONE LEVELS WITH OVULATION IN WOMEN RECEIVING CLOMIPHENE CITRATE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028563
Enrollment
171
Registered
2020-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged between 18 years and 35 years with infertility, Body mass index Women with patency of at least one fallopian tube. Women with PCOS

Exclusion criteria

Exclusion criteria: Endometriosis, Women with AMH level less than 1.5, Women with bilateral tubal blockage, Abnormal HSA of Male partner.

Design outcomes

Primary

MeasureTime frame
1). AMH value will be correlated with ovulation in 3 different groups- 1.AMH- 1.5 to 3.5 , 2.AMH- 3.5 to 5.5, 3.AMH- 5.5. Timepoint: MAY 2020 TO DECEMBER 2021—

Secondary

MeasureTime frame
2).Evidence of Ovulation rates with varying doses of Clomiphene Citrate.Timepoint: MAY 2020 TO DECEMBER 2021—

Countries

India

Contacts

Public ContactDr Prashanth Adiga

KMC Manipal

prashanth.adiga@manipal.edu09035036832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026